Henry Schein, Inc. (HSIC)
Should You Retain Henry Schein Stock in Your Portfolio for Now?
HSIC's growth from its Henry Schein One venture and partnerships is promising, but macro pressures and stiff competition raise concerns for investors.
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analyzing Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC)
Cooper Companies (NASDAQ: COO - Get Free Report) and Henry Schein (NASDAQ: HSIC - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Earnings and Valuation This table compares Cooper Companies
Henry Schein: Still A Buy - But Caution Is Warranted
Henry Schein, Inc. is rated a 'Buy' as signs of improving growth and undervaluation emerge despite recent stagnation. HSIC's recent results show solid revenue and EPS growth, but operating margins and ROIC remain pressured, challenging its economic moat. Management guides for 3–5% sales growth and 5–8% non-GAAP EPS growth in 2026, supported by strategic focus on high-margin businesses and digital transformation.
Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Henry Schein, Inc. (HSIC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Henry Schein, Inc. (HSIC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Henry Schein, Inc. (HSIC) Q4 2025 Earnings Call Transcript
Henry Schein, Inc. (HSIC) Q4 2025 Earnings Call Transcript
Henry Schein (HSIC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down
Henry Schein tops Q4 estimates with 7.8% sales growth, but margin contraction tempers strong equipment, specialty and tech gains.
Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
